Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-23-028005

Director acquired 884 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Drexler Karen Director 2023-11-16 Grant or award +884 8,871 D
Derivatives
Drexler Karen Director 2023-11-16 Grant or award · ResMed Common Stock Options +2,575 $148.90 $383,418 2,575 D
Loading xslF345X05/form4.xml…